View Archive

Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC designates this live activity for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from MorphoSys.

Medical Crossfire®: Bridging Unmet Needs With Emerging Data in Relapsed/Refractory DLBCL to Improve Patient Outcomes

Medical Crossfire®: Bridging Unmet Needs With Emerging Data in Relapsed/Refractory DLBCL to Improve Patient Outcomes

Friday, December 4, 2020

Live, Interactive Virtual Webcast!

11:00 AM – 2:00 PM PST


Diffuse large B-cell lymphoma (DLBCL) is one of the most common forms of non-Hodgkin lymphoma (NHL), accounting for approximately 30% of cases. The treatment landscape of DLBCL is evolving rapidly, particularly for patients with relapsed/refractory disease, with the recent addition of several new active agents to the armamentarium, and numerous other promising therapies in late-stage clinical development. Further, advances in understanding the underlying biology of DLBCL are resulting in more refined biomarker characterization for enhanced risk assessment and individualization of treatment. Clinicians must be aware of these changes and how to integrate them into their practices in order to optimize outcomes for their patients with DLBCL.

This program will utilize PER®’s signature Medical Crossfire® format to highlight current and emerging standards of care in DLBCL. Five expert faculty will present recent and emerging data from key clinical trials, and engage in discussions of how current and investigational agents are changing treatment paradigms in DLBCL, with an emphasis on practical strategies for integrating new therapies in the clinic. New therapeutic approaches and clinical trial options will also be discussed. Participants will have the opportunity to engage in a live question-and-answer session with the faculty, to clarify information and address challenging scenarios in their own clinics.

Benefits of Attending

  • Review recent data and updates in the field of DLBCL
  • Gain expert insights on how to apply emerging evidence and recent approvals to your practice to optimize patient outcomes
  • Learn how to mitigate and manage adverse events associated with newer therapies for DLBCL
  • Discuss investigational approaches for relapsed/refractory DLBCL and clinical trial opportunities for your patients

Acknowledgment of Commercial Support

This activity is supported by an educational grant from MorphoSys.

Target Audience

This educational activity is directed toward medical oncologists/hematologists, nurse practitioners, nurses, and fellows who treat patients with DLBCL. Physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of DLBCL are invited to participate.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Determine state-of-the-art diagnostic approaches that should be utilized to stratify risk and monitor treatment response in multiple lines of care among patients with DLBCL
  • Describe recent landmark evidence in the setting of relapsed/refractory DLBCL and how new strategies can be practically applied to clinical practices
  • Apply methods to monitor for and mitigate the impact of treatment-related toxicities among patients who are managed for DLBCL
  • Evaluate next steps in the field to address unmet clinical needs in DLBCL management, including recent evidence and ongoing clinical trials evaluating novel approaches in multiple lines of care

Program Chair

Gilles A. Salles, MD, PhD
Gilles A. Salles, MD, PhD
Lymphoma Service, Chief
Memorial Sloan Kettering Cancer Center
New York, NY


2 Ways to Register
  1. Online: click here.
  2. Phone: Please call (888) 949-0045 or (609) 378-3701.
Physicians' Education Resource®
2 Clarke Drive
Suite 110
Cranbury, NJ 08512
Registration Fee - Free

For registration assistance, please email info@gotoper.com, or call (888) 949-0045 or (609) 378-3701.

Physicians' Education Resource®, LLC reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited.  This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.

Meeting information is accurate at the time of posting.


You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information

Registration Information

Professional Information


Calendar of Events
Filter By